Furthermore, their discovery suggests the translational utility of gene therapy to deliver functional TDP43 to ALS patients prior to, and early in, symptomatic onset, although further research is necessary to determine the feasibility of this approach. Here, TARDBP is linked to amyotrophic lateral sclerosis.